Inicio › Enfermedad de Alzheimer › Illinois
Ensayos clínicos de Enfermedad de Alzheimer en Illinois
19 estudios sobre Enfermedad de Alzheimer buscan participantes en Illinois.
Ciudades en Illinois
Texto oficial del estudio (inglés)
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Essential Concepts Research Solutions (ECRS), Palos Hills
ReclutandoFase 4
Edades de 50 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07633470Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- RE:Cognition (Chicago), Chicago
- Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville, Chicago
ReclutandoFase 3
Edades de 50 a 90 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Great Lakes Clinical Trials - Andersonville, Chicago
- Southern Illinois University School of Medicine, Springfield
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06976203OTC Hearing Aid and MCI
- Northwestern University HA Lab, Evanston
Reclutando
Edades de 60 a 90 · Todos los sexos · Actualizado el 4 sept 2026 · NCT06112860A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Alexian Brothers Medical Center-Neurosciences ( Site 1017), Elk Grove Village
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 ago 2026 · NCT07033494Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music
- Northwestern University Feinberg School of Medicine, Chicago
Reclutando
Edades de 55 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT07775625A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Re:Cognition Health - Chicago, Chicago
- Ascension Alexian Brothers, Elk Grove Village
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 20 ago 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- John H. Stroger, Jr. Hospital of Cook County, Chicago
- University of Chicago - Medical Center, Chicago
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05552157Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Insigth Hospital and Medical Center Chicago, Chicago
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 90 · Todos los sexos · Actualizado el 14 jul 2026 · NCT07701161A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Great Lakes Clinical Trials - Andersonville, Chicago
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07602582Communication Bridge 3 Study
- University of Chicago - American School Building, Chicago
ReclutandoFase 2
Edades de 18 a 100 · Todos los sexos · Actualizado el 1 jun 2026 · NCT06191198Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Advocate Medical Group Adult Down Syndrome Center, Park Ridge
ReclutandoEstudio observacional
Edades de 25 a 55 · Todos los sexos · Actualizado el 18 may 2026 · NCT04165109Late Onset Alzheimer's Disease
- Rush University, Aurora
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 55 en adelante · Todos los sexos · Actualizado el 18 may 2026 · NCT05010603Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Flourish Research - Chicago, Chicago
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 60 a 90 · Todos los sexos · Actualizado el 15 abr 2026 · NCT06584357Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
- Endeavor Health Systems, Evanston
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 45 en adelante · Todos los sexos · Actualizado el 30 jul 2025 · NCT06254469Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes
- Advanced Personalized Ideation Center (API) and Gatorade Sports Science Institute (GSSI), PepsiCo Global R&D - Life Sciences, Chicago
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 5 jun 2025 · NCT07005895Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Full List of Active Sites, Chicago
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 dic 2023 · NCT06170268De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.